WNKs: New concepts in the regulation of NaCI and K+ balance

Journal of Nephrology

Volumn 20, Issue 3, 2007, Pages 260-264

  Eladari, Dominique ^a,b,c   Chambrey, Regine ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; POTASSIUM; POTASSIUM CHANNEL; PROTEIN KINASE; PROTEIN KINASE WNK; PROTEIN KINASE WNK1; PROTEIN KINASE WNK4; SODIUM CHANNEL; SODIUM CHLORIDE; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; CLINICAL FEATURE; DIETARY INTAKE; HOMEOSTASIS; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOVOLEMIA; KIDNEY DISEASE; KIDNEY TUBULE ACIDOSIS; NONHUMAN; POTASSIUM BALANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOHYPOALDOSTERONISM; SIGNAL TRANSDUCTION; SODIUM ABSORPTION; SODIUM BALANCE;

HUMANS; KIDNEY; POTASSIUM; PROTEIN-SERINE-THREONINE KINASES; SODIUM CHLORIDE;

EID: 35348906747     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-56.
2. Guyton AC. Blood pressure control: special role of the kidneys and body fluids. Science 1991; 252: 1813-6.
3. Gordon RD, Geddes RA, Pawsey CG, O'Halloran MW. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 1970; 19: 287-94.
4. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-12.
5. Gamba G. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. Am J Physiol Renal Physiol 2005; 288: F245-52.
6. Hadchouel J, Delaloy C, Faure S, Achard JM, Jeunemaitre X. Familial hyperkalemic hypertension. J Am Soc Nephrol 2006; 17: 208-17.
7. Kahle KT, Wilson FH, Lifton RP. Regulation of diverse ion transport pathways by WNK4 kinase: a novel molecular switch. Trends Endocrinol Metab 2005; 16: 98-103.
8. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006; 38: 1124-32.
9. Ring AM, Cheng SX, Leng Q, Kahle KT, Rinehart J, Lalioti MD, Volkman HM, Wilson FH, Hebert SC, Lifton RP. WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo. Proc Natl Acad Sci U S A 2007; 104: 4020-4.
10. Ring AM, Leng Q, Rinehart J, Wilson FH, Kahle KT, Hebert SC, Lifton RP. An SGK1 site In WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis. Proc Natl Acad Sci U S A 2007; 104: 4025-9.
11. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006; 86: 1151-78.